torcetrapib has been researched along with gemfibrozil in 1 studies
Studies (torcetrapib) | Trials (torcetrapib) | Recent Studies (post-2010) (torcetrapib) | Studies (gemfibrozil) | Trials (gemfibrozil) | Recent Studies (post-2010) (gemfibrozil) |
---|---|---|---|---|---|
273 | 28 | 83 | 1,483 | 359 | 297 |
Protein | Taxonomy | torcetrapib (IC50) | gemfibrozil (IC50) |
---|---|---|---|
Cytochrome P450 2C8 | Homo sapiens (human) | 4.1 | |
Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 7.0795 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 4.0738 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bloomgarden, ZT | 1 |
1 other study(ies) available for torcetrapib and gemfibrozil
Article | Year |
---|---|
2nd International Symposium on Triglycerides and HDL: lipid abnormalities and their treatment.
Topics: Anticholesteremic Agents; Cholesterol, HDL; Drug Therapy, Combination; Gemfibrozil; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Niacin; Quinolines; Simvastatin; Triglycerides | 2005 |